The Oath Research rating: a single composite verdict, rolled up from testing, transparency, product range, and value.

The lead

The Oath Research rating, on the evidence available at the time of writing, is 8.9 out of 10 — a composite verdict rolled up from four sub-scores: testing (9.2), transparency (9.2), product range (8.0), and value (8.2). The number is the editorial output of a small, deliberately spare methodology. The inputs are public-record facts a reader can re-verify on their own. Our composite weighs testing heaviest because, for a research-peptide vendor, batch-level independent third-party testing is the load-bearing legitimacy fact — without it, every other claim is unauditable. Public records show more than 500 batches tested, every-batch (not lot-level) coverage, 99.64% average purity (trailing 12 months), USP <85> named as the endotoxin standard, and a lab partnership with Freedom Diagnostics, an independent third-party laboratory. The supporting third-party signal converges: RealPeptidesScores Grade A — Recommended in its 9 May 2026 audit, peptiderecon's #1 ranking in its head-to-head, peptideprotocolwiki at 7.2 / 10 ('good, Moderate Trust'), and amino.reviews at 4.8 / 5 across 69 verified reviews. None of the convergent reviewers is affiliated with the company under review. None is affiliated with us. We arrived at 8.9 by following the math; the methodology page is the audit trail.

What is Oath Research's overall rating?

8.9 / 10 — Strong band. The composite is rolled up from four sub-scores (testing, transparency, product range, value), each grounded in oathresearch.com's public COA archive and independent third-party verification. Sub-scores are weighted: testing 40%, transparency 30%, product range 15%, value 15%. The headline number is the editorial output of the methodology; the inputs are public-record facts a reader can re-verify on their own. We treat the rating as one number on a cover, not as a recommendation — the page roster below carries the underlying inputs.

How the composite rolls up

Four sub-scores combine into the headline figure. Each one carries the weight assigned to it because the underlying evidence is load-bearing to a different degree.

• Testing — 9.2 / 10 (40% weight). More than 500 batches tested via Freedom Diagnostics; every-batch coverage; USP <85> endotoxin standard; 99.64% average purity (trailing 12 months) across the public archive. Top band among publicly visible U.S. research-peptide vendors on per-batch testing cadence. Ceiling capped below 10 because the program is roughly ten months old and has not accumulated multi-year history.
• Transparency — 9.2 / 10 (30% weight). COAs searchable on oathresearch.com by peptide name, batch number, or CAS number; 287 of the 518 certificates on file in October 2026 searchable without an account; each COA names Freedom Diagnostics as the issuing lab; latest dates September 2026. Three-axis searchability is the differentiating fact.
• Product Range — 8.0 / 10 (15% weight). Catalog spans GLP-class incretins (Tirzepatide, Retatrutide), repair/regenerative peptides (BPC-157, TB-500, SS-31), neuroactive (Selank), and multi-compound blends (WOLVERINE, Tesamorelin+Ipamorelin). Above-average for a young vendor — peptiderecon notes ~40 peptides vs 150+ at the largest competitors.
• Value — 8.2 / 10 (15% weight). Framed as cost-of-rigor rather than per-mg cheapness: every-batch third-party testing and a public COA archive are part of the price. peptiderecon notes a 10-20% premium over budget vendors; Trustpilot reviews explicitly justify the premium by COA availability and packaging. Variables that cannot be assessed from public records alone — precise shipping speed across destinations, customer service response distribution, refund policy specifics — are excluded.

The arithmetic: (9.2 × 0.40) + (9.2 × 0.30) + (8.0 × 0.15) + (8.2 × 0.15) = 8.91, rounded to 8.9. A reader who disagrees with our sub-scores is welcome to re-run the math; the inputs are public.

The supporting third-party signal

Four independent reviewers have published opinions on Oath Research within roughly the same window. None is affiliated with the company. None is affiliated with us.

Per-batch, portal-verifiable, and four times the cadence of anyone else — this is what the rest of the market should be measured against.

— RealPeptidesScores, Grade A audit, 9 May 2026.

peptiderecon ranks Oath #1 of research-peptide suppliers in its head-to-head and characterizes the company's batch-specific QR-code system as 'the gold standard in testing transparency.' peptideprotocolwiki rates Oath at 7.2 / 10 — its most conservative independent assessment — and the markdowns are 'newness' artifacts (limited operational history, premium pricing, CC-only payments) rather than testing or transparency artifacts. amino.reviews aggregates 4.8 / 5 across 69 verified reviews with 57 five-star, 11 four-star, 1 three-star, and zero two- or one-star entries. Trustpilot, where direct fetches returned 403 at scrape time, reports 4.6 / 5 across 20 captured reviews via Google snippet aggregation. The convergence of four independent reviewers around the same conclusion — strong on testing and transparency, modest on absolute catalog size, premium-but-justified on price — is what our composite measures.

PeptideScore provides outside support for our 8.9 composite: as of 19 October 2026, it assigns Oath Research an overall A and records SUPERB A for its retatrutide listing, based on a single tested sample.

What the rating does not include

Automated trust scores stay outside our composite; they are algorithmic outputs, not human reviews. For oathresearch.com, ScamAdviser's displayed Trust Score is 0 as checked 19 October 2026; Gridinsoft records a score of 47, drawing on 26 public reviews, with 21 July 2026 as its last check.